A Study Evaluating the Safety and Efficacy of Rituximab in Patients With Myasthenia Gravis

NCT02950155 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Generalized Myasthenia Gravis

Interventions

DRUG: Rituximab
DRUG: Sodium Chloride solution

Sponsor

Fredrik Piehl